Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
Shares of biotechnology companies like Viking Therapeutics (NASDAQ: VKTX) have exploded upward by over 300% in the last 12 months, thanks to its phenomenal clinical data from its late-stage weight loss drug program.
The biotech industry is frequently rife with exciting opportunities for the more risk-tolerant investors, and it should come as no surprise that investors who missed the Viking rally may be looking for a similar opportunity within this space that could be just as juicy.
While it's debatable whether the opportunity with Viking is actually in the rearview mirror or merely taking a breather until its next set of clinical catalysts -- and it's probably the latter -- there's another pre-revenue weight loss biotech that's worth paying attention to: Terns Pharmaceuticals (NASDAQ: TERN).
Source Fool.com
Viking Therapeutics Inc Stock
With 6 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 110 € shows a very positive potential of 80.03% compared to the current price of 61.1 € for Viking Therapeutics Inc.
